BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Zhang C, Han N, Luo J, Zhang S, Wang C, Jia Z, Du S. Triglyceride-mimetic prodrugs of scutellarin enhance oral bioavailability by promoting intestinal lymphatic transport and avoiding first-pass metabolism. Drug Deliv 2021;28:1664-72. [PMID: 34338567 DOI: 10.1080/10717544.2021.1960928] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao J, Tian W, Abdullah, Wang H, Chen M, Huang Q, Zhang M, Lu M, Song M, Cao Y. Updated design strategies for oral delivery systems: maximized bioefficacy of dietary bioactive compounds achieved by inducing proper digestive fate and sensory attributes. Crit Rev Food Sci Nutr 2022;:1-20. [PMID: 35959723 DOI: 10.1080/10408398.2022.2109583] [Reference Citation Analysis]
2 Cai L, Xu X, Chen W. The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems. Pharmaceutics 2022;14:1647. [DOI: 10.3390/pharmaceutics14081647] [Reference Citation Analysis]
3 Quach T, Hu L, Han S, Lim SF, Senyschyn D, Yadav P, Trevaksis NL, Simpson JS, Porter CJH. Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport. Front Pharmacol 2022;13:879660. [DOI: 10.3389/fphar.2022.879660] [Reference Citation Analysis]
4 Yoshida T, Kojima H, Sako K, Kondo H. Drug delivery to the intestinal lymph by oral formulations. Pharm Dev Technol 2022;:1-61. [PMID: 35037843 DOI: 10.1080/10837450.2022.2030353] [Reference Citation Analysis]